PROF — Profound Medical Corp.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1628808 ·
Last close
$7.08
Market Cap
$259.32M
52W High
$8.95
52W Low
$4.80
ADV30
306,029
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 9,830,000 | 7,680,000 | -7,821,000 | -7,722,000 | 58,154,000 | 33,343,000 | 15,641,000 |
| Jun 2026 | 2,483,000 | 1,947,000 | -11,066,000 | -9,540,000 | 62,385,000 | 38,271,000 | 12,577,000 |
| Mar 2026 | 5,337,000 | 3,832,000 | -8,021,000 | -7,053,000 | 73,456,000 | 50,295,000 | 14,032,000 |
| Dec 2025 | 5,977,000 | 3,991,000 | -7,369,000 | -8,175,000 | 77,475,000 | 59,723,000 | 11,041,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-36,101,000
Investing CF
—
Financing CF
$41,428,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.98
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-304,333,000
Inventory
$10,456,000
Receivables
$9,614,000
ST Investments
—
EBIT TTM
$-35,369,000
Pretax Income TTM
$-32,518,000
Interest Exp TTM
—
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$19,086,000
EBITDA
$-34,878,000
Free Cash Flow
$-24,819,624
Enterprise Value
$220,453,248
Total Cash
$38,271,000
Total Debt
$7,380,000
Shares Out
36,626,844
Trailing EPS
$-0.99
Book Value
$1.83
ROE
-73.5%
ROA
-39.5%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 16,098,000 | -41,254,000 | -42,570,000 | 77,475,000 | 11,041,000 | 66,434,000 | -38,207,000 |
| Dec 2024 | 10,680,000 | -33,062,000 | -27,816,000 | 70,234,000 | 9,812,000 | 60,422,000 | -23,453,000 |
| Dec 2023 | 7,199,000 | -28,651,000 | -28,323,000 | 43,956,000 | 12,732,000 | 31,224,000 | -22,609,000 |
| Dec 2022 | 6,681,000 | -29,602,000 | -28,669,000 | 64,421,000 | 12,417,000 | 52,004,000 | -25,800,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$19,086,000
NetIncome TTM
$32,744,000
OpCashFlow TTM
—
Assets (Latest)
$62,385,000
Forward EPS
$-0.59
Max Pain — expiry 2027-01-15
max pain strike: $7.50 · spot: $6.91 · call oi: 940 · put oi: 617
Expected Move to 2027-01-15:
±$1.35
(19.54%) —
implied range
$5.56 –
$8.26
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SSII | SS Innovations International, Inc. | $266.51M | $1.33 | — |
| CLPT | ClearPoint Neuro, Inc. | $251.95M | $7.86 | — |
| ZJYL | Jin Medical International Ltd. | $248.61M | $3.38 | — |
| OFIX | Orthofix Medical Inc. | $271.87M | $6.67 | — |
| OSUR | ORASURE TECHNOLOGIES INC | $242.36M | $3.51 | — |
News headlines (Yahoo Finance, 1h cache)
Profound Medical to Participate in the Stifel 2026 Healthcare Conference
2026-11-09 12:45 · Yahoo
Profound Medical And 2 Canadian AI Healthcare Stocks To Watch
2026-11-09 05:11 · Yahoo
What Profound Medical (PROF) Said on Its Q3 Earnings Call
2026-11-06 17:14 · Yahoo
Profound Medical Corp. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
Profound Medical (PROF) Q3 2026 Earnings Call Transcript
2026-11-06 07:01 · Yahoo
Profound Medical Corp (PROF) (Q3 2026) Earnings Call Highlights: Revenue Surges 86% as Pipeline ...
2026-11-06 05:26 · Yahoo
Profound Medical (PROF) Reports Q3 Loss, Beats Revenue Estimates
2026-11-06 00:00 · Yahoo
Profound Medical Reports Strong Third Quarter 2026 Results; Expands U.S. Distribution and Positions Leadership for Next Phase of Growth
2026-11-05 21:05 · Yahoo
Profound Medical (PROF) Expected to Beat Earnings Estimates: Should You Buy?
2026-11-05 14:00 · Yahoo
Wall Street Analysts Believe Profound Medical (PROF) Could Rally 89.93%: Here's is How to Trade
2026-10-30 12:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.